The company's investment in diagnostics firm Recipe is part of an effort to develop its DART mass spec tech for therapeutic drug monitoring and drugs of abuse testing.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Labcorp also becomes a referral lab for the system's seven hospitals and clinical labs and will open three new patient service centers.

Last week, readers were most interested in a story about how the FDA could exert authority over LDTs in the future.